Skip to main content
رجوع
Watch Compare

MEDICINOVA INC

جودة البيانات: 100%
MNOV
Nasdaq Manufacturing Chemicals
KWD 1.45
▲ KWD 0.01 (0.69%)
القيمة السوقية: 71.37 M
السعر
KWD 1.45
القيمة السوقية
71.37 M
نطاق اليوم
KWD 1.40 — KWD 1.45
نطاق 52 أسبوعًا
KWD 1.17 — KWD 1.96
حجم التداول
8,626
فتح KWD 1.40
متوسط 50 يوم / 200 يوم
KWD 1.51
4.23% below
متوسط 50 يوم / 200 يوم
KWD 1.39
4.24% above

Quick Summary

النقاط الرئيسية

Revenue declined -43.56% annually over 5 years
Negative free cash flow of -9.81 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.47%
Capital efficient — spends only 0.71% of revenue on capex

النمو

Revenue Growth (5Y)
-43.56%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-59.03%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-26.42%
أعلى من متوسط القطاع (-53.41%)
ROIC-22.96%
Net Margin-2928.78%
Op. Margin-3242.47%

الأمان

Debt / Equity
N/A
Current Ratio9.86
Interest CoverageN/A

التقييم

PE (TTM)
-5.95
أقل من متوسط القطاع (-1.48)
P/B Ratio1.62
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -6.0 -1.5
P/B 1.6 1.6
ROE % -26.4 -53.4
Net Margin % -2928.8 -41.5
Rev Growth 5Y % -43.6 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -59.03% Revenue Growth (3Y) -36.00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -43.56% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 409,657.0 Net Income (TTM) -12.00 M
ROE -26.42% ROA -24.64%
Gross Margin N/A Operating Margin -3242.47%
Net Margin -2928.78% Free Cash Flow (TTM) -9.81 M
ROIC -22.96% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9.86
Interest Coverage N/A Asset Turnover 0.01
Working Capital 29.59 M Tangible Book Value 34.36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.95 Forward P/E N/A
P/B Ratio 1.62 P/S Ratio 174.22
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -13.75%
Market Cap 71.37 M Enterprise Value 38.81 M
Per Share
EPS (Diluted TTM) -0.24 Revenue / Share 0.01
FCF / Share -0.20 OCF / Share -0.20
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.71% FCF Conversion 81.79%
SBC-Adj. FCF -10.68 M Growth Momentum -15.47

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 409,657.0 1.00 M 1.00 M 4.04 M 4.04 M
Net Income -12.00 M -11.05 M -8.57 M -14.07 M -10.13 M
EPS (Diluted) -0.24 -0.23 -0.17 -0.29 —
Gross Profit — — — — —
Operating Income -13.28 M -12.68 M -9.90 M -14.63 M -10.22 M
EBITDA — — — — —
R&D Expenses 6.70 M 6.80 M 5.30 M 8.70 M 8.10 M
SG&A Expenses — — — — —
D&A 20,099.0 21,077.0 20,295.0 17,707.0 26,149.0
Interest Expense — — — — —
Income Tax 5,994.0 5,537.0 3,047.0 2,822.0 2,568.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 45.60 M 55.88 M 66.27 M 74.15 M 87.41 M
Total Liabilities 4.02 M 3.37 M 3.89 M 3.91 M 3.73 M
Shareholders' Equity 41.59 M 52.50 M 62.38 M 70.24 M 83.68 M
Total Debt — — — — —
Cash & Equivalents 30.81 M 40.36 M 51.00 M 18.51 M 71.43 M
Current Assets 30.99 M 41.07 M 51.17 M 58.99 M 72.01 M
Current Liabilities 3.80 M 2.96 M 3.28 M 3.19 M 2.83 M